CN116731039A - Process for the preparation of cephalosporin derivatives - Google Patents
Process for the preparation of cephalosporin derivatives Download PDFInfo
- Publication number
- CN116731039A CN116731039A CN202310686885.4A CN202310686885A CN116731039A CN 116731039 A CN116731039 A CN 116731039A CN 202310686885 A CN202310686885 A CN 202310686885A CN 116731039 A CN116731039 A CN 116731039A
- Authority
- CN
- China
- Prior art keywords
- reaction
- solution
- ethyl acetate
- methoxymethoxy
- minus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- 230000008569 process Effects 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 150000001780 cephalosporins Chemical class 0.000 title claims abstract description 10
- 229930186147 Cephalosporin Natural products 0.000 title claims abstract description 9
- 229940124587 cephalosporin Drugs 0.000 title claims abstract description 9
- -1 2, 3-di (methoxymethoxy) benzyl Chemical group 0.000 claims abstract description 24
- WVDDGKGOMKODPV-UHFFFAOYSA-N hydroxymethyl benzene Natural products OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims abstract description 17
- KSTAYUMKBHPADG-UHFFFAOYSA-N 2,3-bis(methoxymethoxy)benzaldehyde Chemical compound COCOC1=CC=CC(C=O)=C1OCOC KSTAYUMKBHPADG-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000006467 substitution reaction Methods 0.000 claims abstract description 10
- 230000009467 reduction Effects 0.000 claims abstract description 9
- 235000019445 benzyl alcohol Nutrition 0.000 claims abstract description 8
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 8
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 8
- 238000010511 deprotection reaction Methods 0.000 claims abstract description 6
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 4
- 238000006751 Mitsunobu reaction Methods 0.000 claims abstract description 3
- 230000009435 amidation Effects 0.000 claims abstract description 3
- 238000007112 amidation reaction Methods 0.000 claims abstract description 3
- 238000009833 condensation Methods 0.000 claims abstract description 3
- 230000005494 condensation Effects 0.000 claims abstract description 3
- 238000006698 hydrazinolysis reaction Methods 0.000 claims abstract 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 153
- 238000006243 chemical reaction Methods 0.000 claims description 93
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 69
- 239000000243 solution Substances 0.000 claims description 61
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 57
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 45
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 42
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 41
- 239000000203 mixture Substances 0.000 claims description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 33
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 29
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- IXWOUPGDGMCKGT-UHFFFAOYSA-N 2,3-dihydroxybenzaldehyde Chemical compound OC1=CC=CC(C=O)=C1O IXWOUPGDGMCKGT-UHFFFAOYSA-N 0.000 claims description 25
- 238000010898 silica gel chromatography Methods 0.000 claims description 25
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 25
- 239000002904 solvent Substances 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 22
- 239000007787 solid Substances 0.000 claims description 22
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 20
- 239000000047 product Substances 0.000 claims description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- 229920006395 saturated elastomer Polymers 0.000 claims description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 14
- 239000003208 petroleum Substances 0.000 claims description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 14
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 claims description 14
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 12
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 10
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 10
- 239000005457 ice water Substances 0.000 claims description 10
- 239000012074 organic phase Substances 0.000 claims description 10
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 9
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 claims description 9
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 9
- 229940061627 chloromethyl methyl ether Drugs 0.000 claims description 9
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 9
- 238000010791 quenching Methods 0.000 claims description 9
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 8
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 claims description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 7
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 7
- 239000011541 reaction mixture Substances 0.000 claims description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 7
- 239000003480 eluent Substances 0.000 claims description 6
- 239000012046 mixed solvent Substances 0.000 claims description 5
- 230000000171 quenching effect Effects 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 238000000967 suction filtration Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000012044 organic layer Substances 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000006239 protecting group Chemical group 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims 4
- 238000001816 cooling Methods 0.000 claims 3
- 125000005271 tributylamino group Chemical group 0.000 claims 3
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 claims 2
- 238000005406 washing Methods 0.000 claims 2
- JYOYDYYYMLKKFT-NYNCVSEMSA-N (6r,7r)-7-amino-8-oxo-3-[(2s)-oxolan-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)N)CC=1[C@@H]1CCCO1 JYOYDYYYMLKKFT-NYNCVSEMSA-N 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- BHIIGRBMZRSDRI-UHFFFAOYSA-N [chloro(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(Cl)OC1=CC=CC=C1 BHIIGRBMZRSDRI-UHFFFAOYSA-N 0.000 claims 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims 1
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical class O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 1
- 239000000741 silica gel Substances 0.000 claims 1
- 229910002027 silica gel Inorganic materials 0.000 claims 1
- 238000009210 therapy by ultrasound Methods 0.000 claims 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 22
- 238000001819 mass spectrum Methods 0.000 description 19
- 239000012267 brine Substances 0.000 description 17
- 239000007788 liquid Substances 0.000 description 13
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 10
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 10
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 description 9
- 239000002994 raw material Substances 0.000 description 8
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- 235000019270 ammonium chloride Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 241000282326 Felis catus Species 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 239000002132 β-lactam antibiotic Substances 0.000 description 4
- 229940124586 β-lactam antibiotics Drugs 0.000 description 4
- 239000000589 Siderophore Substances 0.000 description 3
- 125000003172 aldehyde group Chemical group 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000002274 desiccant Substances 0.000 description 3
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- ZJGQFXVQDVCVOK-MSUXKOGISA-N cefovecin Chemical class S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)/C(=N/OC)C=2N=C(N)SC=2)CC=1[C@@H]1CCCO1 ZJGQFXVQDVCVOK-MSUXKOGISA-N 0.000 description 2
- 229960001846 cefovecin sodium Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 229940126142 compound 16 Drugs 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- QRIBXVGHDLFNNE-BMCBYEKFSA-M sodium;(6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[(2s)-oxolan-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound [Na+].S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)/C(=N/OC)C=2N=C(N)SC=2)CC=1[C@@H]1CCCO1 QRIBXVGHDLFNNE-BMCBYEKFSA-M 0.000 description 2
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- IHRDRARBCSMILJ-UHFFFAOYSA-N 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CCCC2CCN12 IHRDRARBCSMILJ-UHFFFAOYSA-N 0.000 description 1
- SCNWTQPZTZMXBG-UHFFFAOYSA-N 2-methyloct-2-enoic acid Chemical compound CCCCCC=C(C)C(O)=O SCNWTQPZTZMXBG-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 108700020474 Penicillin-Binding Proteins Proteins 0.000 description 1
- 206010062255 Soft tissue infection Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000008262 antibiotic resistance mechanism Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- MTJHEMHRSROWNE-UHFFFAOYSA-N bicyclo[4.2.0]oct-4-ene-5-carboxylic acid Chemical compound OC(=O)C1=CCCC2CCC12 MTJHEMHRSROWNE-UHFFFAOYSA-N 0.000 description 1
- 125000006309 butyl amino group Chemical group 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- GFTXWCQFWLOXAT-UHFFFAOYSA-M magnesium;cyclohexane;bromide Chemical compound [Mg+2].[Br-].C1CC[CH-]CC1 GFTXWCQFWLOXAT-UHFFFAOYSA-M 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
技术领域Technical field
本发明涉及一种头孢维星衍生物的制备方法,属于有机合成领域。The invention relates to a preparation method of cefovecin derivatives and belongs to the field of organic synthesis.
背景技术Background technique
头孢维星于1994年由SmithKline Beecham公司首次合成成功,但生产成本较高,后来由辉瑞开发成宠物专用药,于2006年首次在欧盟允许用于猫、狗的皮肤感染治疗,直到2008年美国才允许用于猫、狗的皮肤和软组织感染治疗,目前在我国尚未上市。Ceftavicin was successfully synthesized for the first time by SmithKline Beecham in 1994, but the production cost was high. It was later developed by Pfizer as a pet drug. It was first allowed in the EU in 2006 for the treatment of skin infections in cats and dogs. It was not until 2008 in the United States. It is only allowed to be used for the treatment of skin and soft tissue infections in cats and dogs. It is not currently on the market in my country.
头孢维星钠是目前使用的新型的第三代头孢菌素类动物专用抗生素,其结构特点是在头孢菌素母核C-位通过C-C键链接了四氢呋喃杂环,从而赋予了该产品广谱的抗菌活性和对β-内酰胺酶稳定的特点。头孢维星钠作为抗菌剂具有抗菌谱广,在犬、猫体内具有吸收快、消除缓慢、生物利用度高、安全性好、治疗指数高等优点,是人畜(犬、猫)理想的长效抗生素,目前在兽医临床上已显示出特有的应用前景。如何进一步提高其抗菌活性,避免产生耐药性成为我们急需要研究的问题。Cefovecin sodium is a new third-generation cephalosporin animal-specific antibiotic currently in use. Its structural feature is that a tetrahydrofuran heterocycle is linked through a C-C bond at the C-position of the cephalosporin core, thus giving the product a broad spectrum. Antibacterial activity and stability against β-lactamase. As an antibacterial agent, cefovecin sodium has a broad antibacterial spectrum. It has the advantages of fast absorption, slow elimination, high bioavailability, good safety, and high therapeutic index in dogs and cats. It is an ideal long-acting antibiotic for humans and animals (dogs and cats). , currently has shown unique application prospects in veterinary clinical practice. How to further improve its antibacterial activity and avoid the development of drug resistance has become an urgent issue that we need to study.
研究表明,合成的铁载体-药物耦合物在规避常见抗生素耐药机制,如外膜通透性障碍、相关酶的失活、外排机制等方面是有效的。到目前为止,已有多篇文献报道了关于带有能结合Fe3+的侧链的β-内酰胺类抗生素以及铁载体-β-内酰胺类抗生素耦合物;合成的带有β-内酰胺类抗生素的耦合物具有抗菌活性。当它们通过细菌细胞被摄取后,铁载体-β-内酰胺类抗生素耦合物结合到位于外周胞质的青霉素结合蛋白上,进而抑制了革兰氏阴性菌的生长。为此,我们希望能合成头孢维星的铁载体耦合物。Studies have shown that synthetic siderophore-drug conjugates are effective in circumventing common antibiotic resistance mechanisms, such as outer membrane permeability barriers, inactivation of related enzymes, and efflux mechanisms. So far, there have been many literature reports on β-lactam antibiotics with side chains capable of binding Fe 3+ and siderophore-β-lactam antibiotic couplings; synthetic β-lactam antibiotics Antibiotic-like conjugates possess antibacterial activity. When they are taken up by bacterial cells, siderophore-β-lactam antibiotic conjugates bind to penicillin-binding proteins located in the peripheral cytoplasm, thereby inhibiting the growth of Gram-negative bacteria. To this end, we hoped to synthesize siderophore conjugates of cefavicin.
CN 111620893 A公开了C-3位四氢呋喃取代的头孢菌素-铁载体耦合物及其制备方法和应用,本发明提供了另一种C-3位四氢呋喃取代的头孢菌素-铁载体耦合物及其制备方法。CN 111620893 A discloses a C-3 tetrahydrofuran-substituted cephalosporin-siderophore couple and its preparation method and application. The invention provides another C-3 tetrahydrofuran-substituted cephalosporin-siderophore couple and Its preparation method.
发明内容Contents of the invention
针对上述问题,本发明的目的在于提供一种头孢维星衍生物的制备方法,制作方法简单。In view of the above problems, the object of the present invention is to provide a preparation method of a cefavicin derivative, which is simple.
为了实现上述第一目的,本发明的技术方案为:一种头孢维星衍生物的制备方法,包括以下步骤:In order to achieve the above-mentioned first object, the technical solution of the present invention is: a preparation method of cefovecin derivatives, including the following steps:
(1)、羟基保护:2,3-二羟基苯甲醛与氯甲基甲醚((MOMOCl))反应,得到2,3-二(甲氧基甲氧基)苯甲醛(中间体1);(1) Hydroxy protection: 2,3-dihydroxybenzaldehyde reacts with chloromethyl methyl ether ((MOMOCl)) to obtain 2,3-di(methoxymethoxy)benzaldehyde (intermediate 1);
(2)、还原/取代:还原的步骤为:所得的2,3-二(甲氧基甲氧基)苯甲醛与硼氢化钠反应,得到对应的2,3-二(甲氧基甲氧基)苯甲醇(中间体2);(2) Reduction/substitution: The reduction step is: react the obtained 2,3-bis(methoxymethoxy)benzaldehyde with sodium borohydride to obtain the corresponding 2,3-bis(methoxymethoxy)benzaldehyde. base) benzyl alcohol (intermediate 2);
或取代步骤为:所得的2,3-二(甲氧基甲氧基)苯甲醛与RMgBr反应得到2,3-二(甲氧基甲氧基)苯甲醇的羟基碳取代产物(中间体2)Or the substitution step is: the obtained 2,3-bis(methoxymethoxy)benzaldehyde reacts with RMgBr to obtain the hydroxyl carbon substitution product of 2,3-bis(methoxymethoxy)benzyl alcohol (intermediate 2 )
(3)、Mitsunobu反应:所得的中间体2与N-羟基邻苯二甲酰亚胺反应,得到中间体3;(3) Mitsunobu reaction: The obtained intermediate 2 reacts with N-hydroxyphthalimide to obtain intermediate 3;
(4)、肼解:所得的中间体3与水合肼反应,得到中间体4;(4) Hydrazine solution: The obtained intermediate 3 reacts with hydrazine hydrate to obtain intermediate 4;
(5)、缩合:所得的中间体4与2-氧代-2-(2-(三丁基氨基)噻唑-4-基)乙酸反应,得到中间体5,(5) Condensation: The obtained intermediate 4 reacts with 2-oxo-2-(2-(tributylamino)thiazol-4-yl)acetic acid to obtain intermediate 5,
(6)、酰胺化:所得的中间体5与(6R,7R)-7-氨基-8-氧代-3-((S)-四氢呋喃-2-基)-5-噻-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸酯反应,得到中间体6,(6) Amidation: the obtained intermediate 5 and (6R, 7R)-7-amino-8-oxo-3-((S)-tetrahydrofuran-2-yl)-5-thi-1-aza Reaction of bicyclo[4.2.0]oct-2-ene-2-carboxylate gives intermediate 6,
(7)、脱保护:所得的中间体6与保险粉反应,得到(6R,7R)-7-((Z)-2-(((2,3-双(甲氧基甲氧基)苄基)氧基)亚氨基)-2-(2-(三基氨基)噻唑-4-基)乙酰氨基)-8-氧代-3-((S)-四氢呋喃-2-基)-5-噻-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸及其衍生物(中间体7);(7) Deprotection: The obtained intermediate 6 reacts with insurance powder to obtain (6R, 7R)-7-((Z)-2-(((2,3-bis(methoxymethoxy)benzyl) base)oxy)imino)-2-(2-(triylamino)thiazol-4-yl)acetamido)-8-oxo-3-((S)-tetrahydrofuran-2-yl)-5- Thi-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid and its derivatives (Intermediate 7);
(8)、脱保护:所得的中间体7和三乙基硅烷反应脱去MOMO保护基,得到头孢维星衍生物。(8) Deprotection: The obtained intermediate 7 reacts with triethylsilane to remove the MOMO protecting group to obtain a cefavicin derivative.
上述方案中:步骤(1)中,将2,3-二羟基苯甲醛及其醛基碳取代衍生物溶解于有机溶剂中,冰水浴下加入碳酸钾,控制温度0℃左右,随后缓慢滴加氯甲基甲醚;滴加完成后,将反应升温至室温并继续搅拌反应至反应完全;抽滤除去不溶物,并使用丙酮洗涤;所得滤液真空除去大部分丙酮溶剂后加入乙酸乙酯和水,乙酸乙酯萃取,合并有机相,有机相使用饱和食盐水洗涤,无水硫酸钠干燥,过滤,滤液在真空中浓缩,残留物经石油醚/乙酸乙酯在硅胶柱上层析纯化,得到中间体1。2,3-二羟基苯甲醛的物质的量与有机溶剂(丙酮)的体积之比为1mmol:3.75ml。In the above scheme: in step (1), 2,3-dihydroxybenzaldehyde and its aldehyde carbon-substituted derivatives are dissolved in an organic solvent, potassium carbonate is added in an ice-water bath, the temperature is controlled to about 0°C, and then slowly added dropwise Chloromethyl methyl ether; after the dropwise addition is completed, warm the reaction to room temperature and continue stirring until the reaction is complete; remove the insoluble matter by suction filtration and wash with acetone; remove most of the acetone solvent from the filtrate in a vacuum and add ethyl acetate and water , extracted with ethyl acetate, combined the organic phases, washed the organic phase with saturated brine, dried over anhydrous sodium sulfate, filtered, the filtrate was concentrated in vacuum, and the residue was purified by silica gel column chromatography with petroleum ether/ethyl acetate to obtain Intermediate 1. The ratio of the amount of 2,3-dihydroxybenzaldehyde to the volume of the organic solvent (acetone) is 1mmol:3.75ml.
上述方案中:所述2,3-二羟基苯甲醛、氯甲基甲醚和碳酸钾的物质的量的比为1:3:10。In the above solution: the ratio of the amounts of 2,3-dihydroxybenzaldehyde, chloromethyl methyl ether and potassium carbonate is 1:3:10.
上述方案中:步骤(2)中,还原的步骤为:将中间体1溶解于甲醇中并冷却至0℃,然后分批加入硼氢化钠,随后将反应升温至室温,待反应完成后,减压除去绝大部分甲醇溶剂,残留物中加入水和乙酸乙酯,萃取,饱和食盐水洗涤有机层,无水硫酸钠干燥,过滤后真空浓缩得中间体2,所述中间1和硼氢化钠的物质的量的比为1:3;In the above scheme: in step (2), the reduction step is: dissolve intermediate 1 in methanol and cool to 0°C, then add sodium borohydride in batches, and then warm the reaction to room temperature. After the reaction is completed, reduce Remove most of the methanol solvent under pressure, add water and ethyl acetate to the residue, extract, wash the organic layer with saturated brine, dry it over anhydrous sodium sulfate, filter and concentrate in vacuum to obtain intermediate 2, said intermediate 1 and sodium borohydride The ratio of the amount of substances is 1:3;
取代的步骤为:The replacement steps are:
将中间体1溶于THF溶液在氮气气氛下冷却至零下20℃,然后滴加RMgBr的THF溶液使反应混合物保持在10℃以下,加入之后,将混合物加热至室温,搅拌反应,然后用饱和NH4Cl水溶液缓慢加入使混合物淬灭;溶液用乙酸乙酯提取,用盐水洗涤,用无水硫酸钠干燥,过滤后真空浓缩。以石油谜/乙酸乙酯=10/1为洗脱液,采用硅胶柱层析纯化,得到取代的中间体2,所述R为乙基、甲基、苄基、环己基、苯基中的一种。Intermediate 1 was dissolved in a THF solution and cooled to minus 20°C under a nitrogen atmosphere. Then a THF solution of RMgBr was added dropwise to keep the reaction mixture below 10°C. After addition, the mixture was heated to room temperature, stirred, and then added with saturated NH4Cl. The aqueous solution was slowly added to quench the mixture; the solution was extracted with ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. Using petroleum methane/ethyl acetate = 10/1 as the eluent, purify using silica gel column chromatography to obtain substituted intermediate 2, where R is ethyl, methyl, benzyl, cyclohexyl, or phenyl. A sort of.
上述方案中:步骤(3)中,将中间体2溶解于四氢呋喃和二甲亚砜的混合溶剂中,依次加入N-羟基邻苯二甲酰亚胺和三苯基膦,随后在冰水浴下控制温度0℃,缓慢滴加偶氮二甲酸二异丙酯,加完后,将所得混合物升温至35℃并搅拌反应,待反应完成后加入饱和食盐水溶液进行淬灭,经过后处理得到中间体3;In the above scheme: in step (3), dissolve intermediate 2 in a mixed solvent of tetrahydrofuran and dimethyl sulfoxide, add N-hydroxyphthalimide and triphenylphosphine in sequence, and then add it in an ice-water bath. Control the temperature to 0°C and slowly add diisopropyl azodicarboxylate dropwise. After the addition is completed, heat the resulting mixture to 35°C and stir the reaction. After the reaction is completed, add saturated aqueous sodium chloride solution for quenching. After post-processing, the intermediate is obtained. 3;
中间体2、N-羟基邻苯二甲酰亚胺、三苯基膦和偶氮二异丙酯的物质的量的比为1:1.2-1.4:1.5-2:1.5-2。The ratio of the amounts of intermediate 2, N-hydroxyphthalimide, triphenylphosphine and azobisisopropyl ester is 1:1.2-1.4:1.5-2:1.5-2.
上述方案中:步骤(4)为:将中间体3溶于乙醇中,加入水合肼,在室温下搅拌反应至反应完全,滤除固体,再加入水,用乙酸乙酯萃取,得到中间体4;中间体3和水合肼的物质的量的比为1:1.5-2。In the above scheme: step (4) is: dissolve intermediate 3 in ethanol, add hydrazine hydrate, stir the reaction at room temperature until the reaction is complete, filter out the solid, then add water, and extract with ethyl acetate to obtain intermediate 4. ; The ratio of the amounts of intermediate 3 and hydrazine hydrate is 1:1.5-2.
上述方案中:步骤(5)为:在氮气氛围下,将中间体4溶解于乙醇中,随后加入化合物2-氧代-2-(2-(三丁基氨基)噻唑-4-基)乙酸和醋酸,混合物在60℃-70℃下搅拌反应得到中间体5,In the above scheme: step (5) is: dissolve intermediate 4 in ethanol under nitrogen atmosphere, and then add compound 2-oxo-2-(2-(tributylamino)thiazol-4-yl)acetic acid. and acetic acid, the mixture is stirred at 60°C-70°C to react to obtain intermediate 5,
中间体4和2-氧代-2-(2-(三丁基氨基)噻唑-4-基)乙酸的物质的量的比为1:1-1.1。The material amount ratio of intermediate 4 and 2-oxo-2-(2-(tributylamino)thiazol-4-yl)acetic acid is 1:1-1.1.
上述方案中:步骤(6)为:在氮气氛围下,将中间体5溶解于N,N-二甲基甲酰胺中,在零下30℃下依次滴加化合物氯磷酸二苯酯和N,N-二异丙基乙基胺,在零下30℃反应2小时后,加入零下30℃冷却过的化合物(6R,7R)-7-氨基-8-氧代-3-((S)-四氢呋喃-2-基)-5-噻-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸酯的N,N-二甲基甲酰胺溶液,混合物在零下30℃下继续搅拌反应得到中间体6。In the above scheme: step (6) is: dissolve intermediate 5 in N,N-dimethylformamide under a nitrogen atmosphere, and add the compounds diphenyl chlorophosphate and N,N in sequence at minus 30°C. -Diisopropylethylamine, after reacting at minus 30°C for 2 hours, add compound (6R, 7R)-7-amino-8-oxo-3-((S)-tetrahydrofuran-) that has been cooled at minus 30°C. A solution of 2-yl)-5-thi-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate in N,N-dimethylformamide, the mixture was stirred at minus 30°C. The reaction yields intermediate 6.
上述方案中:步骤(7)为:将中间体6溶解于乙腈和水的混合溶液中,然后将所得混合物升温至40℃,加入碳酸氢钠,5分钟后加入保险粉;溶液在40℃下搅拌反应得到中间体7。In the above scheme: step (7) is: dissolve intermediate 6 in a mixed solution of acetonitrile and water, then heat the resulting mixture to 40°C, add sodium bicarbonate, and add insurance powder after 5 minutes; the solution is heated at 40°C. The reaction was stirred to obtain intermediate 7.
上述方案中:步骤(8)为:将中间体7溶解于无水二氯甲烷中,然后加入三乙基硅烷并将所得混合物冷却至零下15℃,加入三氟乙酸,溶液在零下15℃下搅拌反应11-13小时后,将反应液逐步升温至室温继续搅拌反应至反应完全,真空浓缩除去挥发物和溶剂后,残留物加入叔丁基甲基醚得到白色固体,在超声波中超声,离心,将上层清液除去,继续重复叔丁基甲基醚-超声-离心步骤两次,所得固体经减压除去溶剂后即为产物。In the above scheme: step (8) is: dissolve intermediate 7 in anhydrous dichloromethane, then add triethylsilane and cool the resulting mixture to minus 15°C, add trifluoroacetic acid, and keep the solution at minus 15°C. After stirring for 11-13 hours, gradually raise the temperature of the reaction solution to room temperature and continue to stir the reaction until the reaction is complete. After vacuum concentration to remove volatile matter and solvent, add tert-butyl methyl ether to the residue to obtain a white solid. Ultrasonicate in ultrasonic waves, centrifuge, and The supernatant liquid is removed, and the tert-butyl methyl ether-ultrasonic-centrifugation steps are repeated twice. The solid obtained is the product after removing the solvent under reduced pressure.
中间体1的物质的量与甲醇的体积之比为1mmol:2mL。The ratio of the amount of intermediate 1 to the volume of methanol is 1 mmol:2 mL.
中间体2的物质的量与四氢呋喃和二甲亚砜的体积之比为1mmol:1.6mL:0.8mL。反应时间为1.5-12h。The ratio of the amount of intermediate 2 to the volumes of tetrahydrofuran and dimethyl sulfoxide is 1 mmol: 1.6 mL: 0.8 mL. The reaction time is 1.5-12h.
中间体3的物质的量与乙醇的体积之比为1mmol:5mL。The ratio of the amount of intermediate 3 to the volume of ethanol is 1 mmol: 5 mL.
中间体4的物质的量与醋酸的体积之比为138mmol:1mL。The ratio of the amount of intermediate 4 to the volume of acetic acid is 138 mmol: 1 mL.
中间体5的物质的量与N,N-二甲基甲酰胺的体积之比为1mmol:1.2mL,反应时间为12h左右。The ratio of the amount of intermediate 5 to the volume of N,N-dimethylformamide is 1mmol:1.2mL, and the reaction time is about 12h.
中间体6的物质的量与乙腈和水的体积之比为1mmol:3.6mL:1.2mL。反应时间为0.2h。The ratio of the amount of intermediate 6 to the volume of acetonitrile and water is 1 mmol: 3.6 mL: 1.2 mL. The reaction time is 0.2h.
中间体7的物质的量与二氯甲烷的体积之比为1mmol:5mL,反应时间为15h左右。The ratio of the amount of intermediate 7 to the volume of methylene chloride is 1mmol:5mL, and the reaction time is about 15h.
与现有技术相比,本发明的有益效果为:Compared with the prior art, the beneficial effects of the present invention are:
(1)、原料与试剂更加价廉易得:反应所用原料与试剂,均为成熟的市售产品,价格低廉,供应稳定,可确保工业化生产稳定的原材料供应。目前采用的方法为用2,3-二羟基苯甲醛的醛基上碳取代的衍生物,经过羟基保护,然后再还原醛基的步骤制备中间体2,原材料(2,3-二羟基苯甲醛的醛基上碳取代的衍生物)不常见,价格贵,本发明原料与试剂更加价廉易得:反应所用原料与试剂,均为成熟的市售产品,价格低廉,供应稳定,可确保工业化生产稳定的原材料供应。(1) Raw materials and reagents are cheaper and easier to obtain: The raw materials and reagents used in the reaction are all mature commercial products with low prices and stable supply, which can ensure a stable supply of raw materials for industrial production. The currently used method is to use a carbon-substituted derivative of the aldehyde group of 2,3-dihydroxybenzaldehyde, protect the hydroxyl group, and then reduce the aldehyde group to prepare intermediate 2. The raw material (2,3-dihydroxybenzaldehyde Derivatives substituted by carbon on the aldehyde group) are uncommon and expensive. The raw materials and reagents of the present invention are cheaper and easier to obtain: the raw materials and reagents used in the reaction are mature commercial products with low prices and stable supply, which can ensure industrialization. Produce a stable supply of raw materials.
(2)、用于合成头孢维星衍生物反应步骤短:从主原料2,3-二羟基苯甲醛出发,经过取代还原等步骤,也仅需八步反应,即可得到产品,与传统合成路线相比,反应更便捷,有利于降低生产成本。(2) The reaction steps for synthesizing cefavicin derivatives are short: starting from the main raw material 2,3-dihydroxybenzaldehyde, through substitution and reduction steps, the product can be obtained in only eight steps, which is different from traditional synthesis. Compared with other routes, the response is more convenient and helps reduce production costs.
(3)、操作过程更加简便:各步反应之间,采用最简洁的方式进行衔接,使得整个反应过程更加流畅,有利于提升合成效率,提高反应总收率。(3) The operation process is simpler: The simplest way is used to connect each reaction step, making the entire reaction process smoother, which is beneficial to improving the synthesis efficiency and increasing the overall reaction yield.
(4)、原子经济性更优:整个反应过程,仅有少量离去基团,且离去基团均为常见小分子化合物,价值较低,体现出合成路线较高的原子经济性。(4) Better atom economy: There are only a small number of leaving groups in the entire reaction process, and the leaving groups are common small molecule compounds with low value, reflecting the high atom economy of the synthesis route.
附图说明Description of drawings
图1为实施例1的中间体1的质谱图。Figure 1 is a mass spectrum of Intermediate 1 of Example 1.
图2为实施例1的中间体4的质谱图。Figure 2 is a mass spectrum of Intermediate 4 of Example 1.
图3为实施例1的中间体5的质谱图。Figure 3 is a mass spectrum of intermediate 5 in Example 1.
图4为实施例1的中间体6的质谱图。Figure 4 is a mass spectrum of intermediate 6 in Example 1.
图5实施例1的中间体7的质谱图。Figure 5 is a mass spectrum of intermediate 7 of Example 1.
图6为实施例2的化合物3的质谱图。Figure 6 is a mass spectrum of compound 3 in Example 2.
图7为实施例2的化合物5的质谱图。Figure 7 is a mass spectrum of compound 5 in Example 2.
图8为实施例2产品6的质谱图。Figure 8 is the mass spectrum of product 6 in Example 2.
图9为实施例2的化合物8的质谱图。Figure 9 is the mass spectrum of compound 8 in Example 2.
图10为实施例3的液体3的质谱图。Figure 10 is a mass spectrum of Liquid 3 in Example 3.
图11为实施例3产品5的质谱图。Figure 11 is the mass spectrum of product 5 in Example 3.
图12为实施例3产品6的质谱图。Figure 12 is the mass spectrum of product 6 in Example 3.
图13为实施例3的产品8的质谱图。Figure 13 is the mass spectrum of product 8 of Example 3.
图14为实施例4的液体9的质谱图。Figure 14 is a mass spectrum of Liquid 9 in Example 4.
图15为实施例5的液体10的质谱图。Figure 15 is a mass spectrum of the liquid 10 of Example 5.
图16为实施例6的液体11的质谱图。Figure 16 is a mass spectrum of Liquid 11 of Example 6.
具体实施方式Detailed ways
下面通过具体实施例并结合附图,对本发明作进一步说明:The present invention will be further described below through specific embodiments and in conjunction with the accompanying drawings:
实施例1Example 1
步骤1:step 1:
配料比Ingredient ratio
反应式为:The reaction formula is:
将2,3-二羟基苯甲醛11.1g溶解于丙酮300m L中,冰水浴下加入碳酸钾55.2g,随后缓慢滴加氯甲基甲醚18.2mL。滴加完成后,将反应升温至室温并继续搅拌30分钟。反应完成后,抽滤除去不溶物,并使用丙酮洗涤。所得滤液真空除去大部分丙酮溶剂后加入乙酸乙酯和水,乙酸乙酯萃取,合并有机相,有机相使用饱和食盐水洗涤,无水硫酸钠干燥,过滤,滤液在真空中浓缩,残留物经石油醚/乙酸乙酯在硅胶柱上层析纯化,石油醚/乙酸乙酯的体积比为20/1,得到无色液体2,3-二(甲氧基甲氧基)苯甲醛17.45g,收率96%。1H NMR(400MHz,Chloroform-d)δ10.46(s,1H),7.51(d,J=7.8Hz,1H),7.41(d,J=8.2Hz,1H),7.21–7.10(m,1H),5.26(s,2H),5.24(s,2H),3.58(s,3H),3.52(s,3H).质谱如图1所示。Dissolve 11.1g of 2,3-dihydroxybenzaldehyde in 300mL of acetone, add 55.2g of potassium carbonate in an ice-water bath, and then slowly add 18.2mL of chloromethyl methyl ether dropwise. After the addition was complete, the reaction was warmed to room temperature and stirring continued for 30 minutes. After the reaction was completed, the insoluble matter was removed by suction filtration and washed with acetone. The obtained filtrate was vacuumed to remove most of the acetone solvent, then added ethyl acetate and water, extracted with ethyl acetate, combined the organic phases, washed with saturated brine, dried over anhydrous sodium sulfate, filtered, the filtrate was concentrated in vacuum, and the residue was Petroleum ether/ethyl acetate was purified by silica gel column chromatography. The volume ratio of petroleum ether/ethyl acetate was 20/1 to obtain 17.45g of colorless liquid 2,3-bis(methoxymethoxy)benzaldehyde. The yield is 96%. 1 H NMR (400MHz, Chloroform-d) δ10.46 (s, 1H), 7.51 (d, J = 7.8Hz, 1H), 7.41 (d, J = 8.2Hz, 1H), 7.21–7.10 (m, 1H ), 5.26(s,2H), 5.24(s,2H), 3.58(s,3H), 3.52(s,3H). The mass spectrum is shown in Figure 1.
步骤2:Step 2:
配料比:Ingredients ratio:
反应式:Reaction formula:
将2,3-二(甲氧基甲氧基)苯甲醛12.0g溶解于甲醇100mL中并冷却至0℃,然后分批加入硼氢化钠6.03g,随后将反应升温至室温,待反应完成后(TLC检测),减压除去绝大部分甲醇溶剂,残留物中加入水和乙酸乙酯,乙酸乙酯萃取,饱和食盐水洗涤,无水硫酸钠干燥,过滤后真空浓缩得白色固体2,3-二(甲氧基甲氧基)苯甲醇11.4g,收率94%Dissolve 12.0g of 2,3-bis(methoxymethoxy)benzaldehyde in 100mL of methanol and cool to 0°C, then add 6.03g of sodium borohydride in batches, and then warm the reaction to room temperature until the reaction is completed. (TLC detection), remove most of the methanol solvent under reduced pressure, add water and ethyl acetate to the residue, extract with ethyl acetate, wash with saturated brine, dry over anhydrous sodium sulfate, filter and concentrate in vacuum to obtain a white solid 2,3 -Bis(methoxymethoxy)benzyl alcohol 11.4g, yield 94%
步骤3:Step 3:
步骤3和4的配料比Ingredients ratio for steps 3 and 4
反应式:Reaction formula:
将2,3-二(甲氧基甲氧基)苯甲醇11.4g溶解于四氢呋喃80mL和二甲亚砜40mL的混合溶剂中,依次加入N-羟基邻苯二甲酰亚胺9.79g和三苯基膦19.7g,随后在冰水浴下缓慢滴加偶氮二甲酸二异丙酯14.8mL30分钟。加入之后,将所得混合物升温至35℃并搅拌1h,待反应完成后加入饱和食盐水溶液进行淬灭。溶液用乙酸乙酯提取,用饱和碳酸氢钠水溶液和盐水洗涤,有机相用无水硫酸钠干燥,过滤,然后将滤液真空浓缩,得到2-((2,3-二(甲氧基甲氧基)苄氧基)异吲哚啉-1,3-二酮中间体3粗品。Dissolve 11.4g of 2,3-bis(methoxymethoxy)benzyl alcohol in a mixed solvent of 80mL of tetrahydrofuran and 40mL of dimethyl sulfoxide, and add 9.79g of N-hydroxyphthalimide and triphenyl in sequence. 19.7g of base phosphine was added, and then 14.8mL of diisopropyl azodicarboxylate was slowly added dropwise in an ice-water bath for 30 minutes. After the addition, the resulting mixture was heated to 35°C and stirred for 1 hour. After the reaction was completed, saturated saline solution was added for quenching. The solution was extracted with ethyl acetate, washed with saturated aqueous sodium bicarbonate solution and brine, the organic phase was dried with anhydrous sodium sulfate, filtered, and the filtrate was concentrated in vacuo to obtain 2-((2,3-bis(methoxymethoxy) Base) benzyloxy) isoindoline-1,3-dione intermediate 3 crude product.
步骤4Step 4
反应式:Reaction formula:
将2-((2,3-二(甲氧基甲氧基)苄氧基)异吲哚啉-1,3-二酮粗产品溶于乙醇250mL中,加入80%水合肼4.55mL,并使所得混合物在室温下搅拌1h。滤除固体,再加入水180mL,用乙酸乙酯萃取混合物,用饱和碳酸氢钠水溶液和盐水洗涤,用无水硫酸钠干燥,过滤,然后将滤液真空浓缩。经二氯甲烷/甲醇在硅胶柱上层析纯化,二氯甲烷/甲醇的体积比二。氯甲烷/甲醇=20/1,得到白色固体O-(2,3-二(甲氧基甲氧基)苄基)羟胺8.28g,两步产率68%Dissolve the crude product of 2-((2,3-di(methoxymethoxy)benzyloxy)isoindoline-1,3-dione in 250 mL of ethanol, add 4.55 mL of 80% hydrazine hydrate, and The resulting mixture was stirred at room temperature for 1 h. The solid was filtered off, and 180 mL of water was added. The mixture was extracted with ethyl acetate, washed with saturated aqueous sodium bicarbonate solution and brine, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated in vacuo. Purified by silica gel column chromatography with methylene chloride/methanol, the volume ratio of methylene chloride/methanol is 2. Methyl chloride/methanol = 20/1, and a white solid O-(2,3-bis(methoxymethoxy) is obtained. Benzyl)hydroxylamine 8.28g, two-step yield 68%
步骤5:Step 5:
配料比Ingredient ratio
在氮气氛围下,将化合物O-(2,3-二(甲氧基甲氧基)苄基)羟胺8.28g溶解于乙醇100mL中,随后加入化合物2-氧代-2-(2-(三丁基氨基)噻唑-4-基)乙酸14.1g和5滴醋酸,混合物在60℃下搅拌6小时,反应结束后,过滤除去不溶物,滤液减压蒸除溶剂,用二氯甲烷/甲醇(9/1)在硅胶上层析纯化得到(Z)-2-((2,3-双(甲氧基甲氧基)苄氧基)亚氨基)-2-(2-(三丁基氨基)噻唑-4-基)乙酸19.30g,产率89%。Under a nitrogen atmosphere, 8.28g of compound O-(2,3-di(methoxymethoxy)benzyl)hydroxylamine was dissolved in 100 mL of ethanol, and then compound 2-oxo-2-(2-(tris Butylamino)thiazol-4-yl)acetic acid 14.1g and 5 drops of acetic acid, the mixture was stirred at 60°C for 6 hours. After the reaction was completed, the insoluble matter was removed by filtration, the solvent was evaporated from the filtrate under reduced pressure, and the mixture was heated with dichloromethane/methanol ( 9/1) Purify by silica gel chromatography to obtain (Z)-2-((2,3-bis(methoxymethoxy)benzyloxy)imino)-2-(2-(tributylamino) )thiazol-4-yl)acetic acid 19.30g, yield 89%.
步骤6:Step 6:
配料比:Ingredients ratio:
在氮气氛围下,将化合物(Z)-2-((2,3-双(甲氧基甲氧基)苄氧基)亚氨基)-2-(2-(三丁基氨基)噻唑-4-基)乙酸2.02g溶解于N,N-二甲基甲酰胺8.0mL中,在零下30℃下依次滴加化合物氯磷酸二苯酯588μL和N,N-二异丙基乙基胺1.04mL,在零下30℃反应2小时后,加入零下30℃冷却过的化合物(6R,7R)-7-氨基-8-氧代-3-((S)-四氢呋喃-2-基)-5-噻-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸酯(16)810.8mg,的N,N-二甲基甲酰胺16.0mL溶液,混合物在零下30℃下搅拌12小时,反应结束后,加入饱和碳酸氢钠淬灭反应,乙酸乙酯萃取,依次使用水和饱和食盐水洗涤,无水硫酸钠干燥,过滤除去不溶物,滤液减压蒸除溶剂,用乙酸乙酯在硅胶上层析纯化得到4-硝基苯基(6R,7R)-7-((Z)-2-(((2,3-双(甲氧基甲氧基)苄基)氧基)亚氨基)-2-(2-(三基氨基)噻唑-4-基)乙酰胺基)-8-氧代-3-(((S)-四氢呋喃-2-基)-5-噻-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸酯1.68g,产率82%。Under a nitrogen atmosphere, compound (Z)-2-((2,3-bis(methoxymethoxy)benzyloxy)imino)-2-(2-(tributylamino)thiazole-4 2.02g of -ethyl)acetic acid was dissolved in 8.0mL of N,N-dimethylformamide, and 588μL of the compound diphenyl chlorophosphate and 1.04mL of N,N-diisopropylethylamine were added dropwise at minus 30°C. , after reacting at minus 30°C for 2 hours, add the compound (6R, 7R)-7-amino-8-oxo-3-((S)-tetrahydrofuran-2-yl)-5-thi which has been cooled at minus 30°C. -1-Azabicyclo[4.2.0]oct-2-ene-2-carboxylate (16) 810.8 mg, a solution of 16.0 mL of N,N-dimethylformamide, the mixture was stirred at minus 30°C for 12 hours, after the reaction is completed, add saturated sodium bicarbonate to quench the reaction, extract with ethyl acetate, wash with water and saturated brine in sequence, dry with anhydrous sodium sulfate, filter to remove insoluble matter, evaporate the solvent from the filtrate under reduced pressure, and use ethyl acetate to The ester was purified by silica gel chromatography to obtain 4-nitrophenyl (6R, 7R)-7-((Z)-2-(((2,3-bis(methoxymethoxy)benzyl)oxy) )imino)-2-(2-(triylamino)thiazol-4-yl)acetamido)-8-oxo-3-(((S)-tetrahydrofuran-2-yl)-5-thi- 1.68 g of 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, yield 82%.
步骤7:Step 7:
配料比:Ingredients ratio:
将4-硝基苯基(6R,7R)-7-((Z)-2-(((2,3-双(甲氧基甲氧基)苄基)氧基)亚氨基)-2-(2-(三基氨基)噻唑-4-基)乙酰胺基)-8-氧代-3-(((S)-四氢呋喃-2-基)-5-噻-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸酯1.23g溶解于乙腈43.0mL和水14.0mL的混合溶液中,然后将所得混合物升温至40℃,加入碳酸氢钠4.46g,5分钟后加入保险粉3.08g。溶液在40℃下搅拌10分钟,反应完成后,将反应液倒入二氯甲烷和水的混合溶液中,随后使用17%盐酸将pH调至3,二氯甲烷萃取,饱和食盐水洗涤,无水硫酸钠干燥,过滤除去干燥剂后真空浓缩。残留物经二氯甲烷/甲醇在硅胶柱上层析纯化,二氯甲烷/甲醇的体积比为20/1。得到棕黄色固体(6R,7R)-7-((Z)-2-(((2,3-双(甲氧基甲氧基)苄基)氧基)亚氨基)-2-(2-(三基氨基)噻唑-4-基)乙酰氨基)-8-氧代-3-((S)-四氢呋喃-2-基)-5-噻-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸1.01g,产率94%。4-Nitrophenyl(6R,7R)-7-((Z)-2-(((2,3-bis(methoxymethoxy)benzyl)oxy)imino)-2- (2-(Triylamino)thiazol-4-yl)acetamido)-8-oxo-3-(((S)-tetrahydrofuran-2-yl)-5-thi-1-azabicyclo[4.2 .0] 1.23g of oct-2-ene-2-carboxylate was dissolved in a mixed solution of 43.0mL of acetonitrile and 14.0mL of water, then the resulting mixture was heated to 40°C, 4.46g of sodium bicarbonate was added, and added after 5 minutes. 3.08g insurance powder. Stir the solution for 10 minutes at 40°C. After the reaction is completed, pour the reaction solution into a mixed solution of methylene chloride and water, then use 17% hydrochloric acid to adjust the pH to 3, extract with methylene chloride, and saturate Wash with brine, dry over anhydrous sodium sulfate, filter to remove the desiccant and concentrate in vacuum. The residue is purified by silica gel column chromatography with dichloromethane/methanol. The volume ratio of dichloromethane/methanol is 20/1. A brown color is obtained Solid (6R, 7R)-7-((Z)-2-(((2,3-bis(methoxymethoxy)benzyl)oxy)imino)-2-(2-(triyl) Amino)thiazol-4-yl)acetamido)-8-oxo-3-((S)-tetrahydrofuran-2-yl)-5-thi-1-azabicyclo[4.2.0]oct-2-ene -2-carboxylic acid 1.01g, yield 94%.
步骤8:Step 8:
氮气氛围下,将(6R,7R)-7-((Z)-2-(((2,3-双(甲氧基甲氧基)苄基)氧基)亚氨基)-2-(2-(三基氨基)噻唑-4-基)乙酰氨基)-8-氧代-3-((S)-四氢呋喃-2-基)-5-噻-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸900mg溶解于无水二氯甲烷5mL中,然后加入三乙基硅烷479μL并将所得混合物冷却至零下15℃,加入三氟乙酸7.65mL。溶液在零下15℃下搅拌12小时后,将反应液逐步升温至室温继续搅拌3小时。真空浓缩除去挥发物和溶剂后,残留物加入叔丁基甲基醚得到白色固体,在超声波中超声10分钟后,使用离心机离心10分钟,将上层清液除去,继续重复叔丁基甲基醚-超声-离心步骤两次,所得固体经油泵减压除去溶剂后即为产物头孢维星540mg,产率96%。Under a nitrogen atmosphere, (6R, 7R)-7-((Z)-2-(((2,3-bis(methoxymethoxy)benzyl)oxy)imino)-2-(2 -(Triylamino)thiazol-4-yl)acetamido)-8-oxo-3-((S)-tetrahydrofuran-2-yl)-5-thi-1-azabicyclo[4.2.0]octane Dissolve 900 mg of -2-ene-2-carboxylic acid in 5 mL of anhydrous dichloromethane, then add 479 μL of triethylsilane, cool the resulting mixture to minus 15°C, and add 7.65 mL of trifluoroacetic acid. After the solution was stirred at minus 15°C for 12 hours, the reaction solution was gradually warmed to room temperature and continued to stir for 3 hours. After vacuum concentration to remove volatile matter and solvent, tert-butyl methyl ether was added to the residue to obtain a white solid. After ultrasonic for 10 minutes, centrifuge for 10 minutes using a centrifuge to remove the supernatant and continue to repeat tert-butyl methyl ether - ultrasonic - After centrifugation step twice, the solid obtained was decompressed by an oil pump to remove the solvent, and the product cefavicin was 540 mg, with a yield of 96%.
实施例2Example 2
步骤(1)step 1)
1、化学反应式1. Chemical reaction formula
2、投料配比2. Feeding ratio
将2,3-二羟基苯甲醛11.1g溶解于丙酮300m L中,冰水浴下加入碳酸钾55.2g,随后缓慢滴加氯甲基甲醚18.2mL。滴加完成后,将反应升温至室温并继续搅拌30分钟。反应完成后,抽滤除去不溶物,并使用丙酮洗涤。所得滤液真空除去大部分丙酮溶剂后加入乙酸乙酯和水,乙酸乙酯萃取,合并有机相,有机相使用饱和食盐水洗涤,无水硫酸钠干燥,过滤,滤液在真空中浓缩,残留物经石油醚/乙酸乙酯在硅胶柱上层析纯化,石油醚/乙酸乙酯的体积比为20/1,得到无色液体2 17.45g,收率96%。1H NMR(400MHz,Chloroform-d)δ10.46(s,1H),7.51(d,J=7.8Hz,1H),7.41(d,J=8.2Hz,1H),7.21–7.10(m,1H),5.26(s,2H),5.24(s,2H),3.58(s,3H),3.52(s,3H).质谱如图1所示。Dissolve 11.1g of 2,3-dihydroxybenzaldehyde in 300mL of acetone, add 55.2g of potassium carbonate in an ice-water bath, and then slowly add 18.2mL of chloromethyl methyl ether dropwise. After the addition was complete, the reaction was warmed to room temperature and stirring continued for 30 minutes. After the reaction was completed, the insoluble matter was removed by suction filtration and washed with acetone. The obtained filtrate was vacuumed to remove most of the acetone solvent, then added ethyl acetate and water, extracted with ethyl acetate, combined the organic phases, washed with saturated brine, dried over anhydrous sodium sulfate, filtered, the filtrate was concentrated in vacuum, and the residue was Petroleum ether/ethyl acetate was purified by silica gel column chromatography. The volume ratio of petroleum ether/ethyl acetate was 20/1 to obtain 17.45g of colorless liquid 2 with a yield of 96%. 1 H NMR (400MHz, Chloroform-d) δ10.46 (s, 1H), 7.51 (d, J = 7.8Hz, 1H), 7.41 (d, J = 8.2Hz, 1H), 7.21–7.10 (m, 1H ), 5.26(s,2H), 5.24(s,2H), 3.58(s,3H), 3.52(s,3H). The mass spectrum is shown in Figure 1.
二、步骤21、化学反应式2. Step 21. Chemical reaction formula
2、投料配比2. Feeding ratio
将2溶于THF溶液在氮气气氛下冷却至零下20℃,然后滴加甲基溴化镁的THF溶液使反应混合物保持在10℃以下。加入之后,将混合物加热至室温,搅拌3小时,然后用饱和NH4Cl水溶液缓慢加入使混合物淬灭。溶液用乙酸乙酯提取,用盐水洗涤,用无水硫酸钠干燥,过滤后真空浓缩。以石油谜/乙酸乙酯=10/1硅胶柱层析纯化,得到液体3(9.16g,产率91.6%)。A solution of 2 dissolved in THF was cooled to minus 20°C under a nitrogen atmosphere, and then a THF solution of methylmagnesium bromide was added dropwise to keep the reaction mixture below 10°C. After addition, the mixture was warmed to room temperature, stirred for 3 hours, and then quenched with saturated aqueous NH4Cl solution added slowly. The solution was extracted with ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. Purify by silica gel column chromatography using petroleum ethyl acetate = 10/1 to obtain liquid 3 (9.16 g, yield 91.6%).
1H NMR(400MHz,Chloroform-d)δ7.06–6.90(m,3H),5.18–5.12(m,1H),5.10(q,J=2.4,1.9Hz,2H),5.09–5.01(m,2H),3.50(d,J=2.6Hz,3H),3.41(d,J=2.3Hz,3H),2.82(s,1H),1.59–1.29(m,3H).1H NMR(400MHz,Chloroform-d)δ7.06–6.90(m,3H),5.18–5.12(m,1H),5.10(q,J=2.4,1.9Hz,2H),5.09–5.01(m,2H ),3.50(d,J=2.6Hz,3H),3.41(d,J=2.3Hz,3H),2.82(s,1H),1.59–1.29(m,3H).
步骤31、化学反应式Step 31. Chemical reaction formula
2、投料配比(包括步骤4的投料比)2. Feeding ratio (including the feeding ratio in step 4)
操作过程Operation process
将3溶解于四氢呋喃80mL和二甲亚砜4mL的混合溶剂中,依次加入4和三苯基膦,随后在冰水浴下缓慢滴加偶氮二异丙酯30分钟。加入之后,将所得混合物升温至35℃并搅拌1h,TLC监测反应,待反应完成后加入饱和食盐水溶液进行淬灭。溶液用乙酸乙酯提取,用饱和碳酸氢钠水溶液和盐水洗涤,有机相用无水硫酸钠干燥,过滤,然后将滤液真空浓缩。经二氯甲烷/甲醇=20/1硅胶层析纯化。得到5(1.69g,产率88%)。Dissolve 3 in a mixed solvent of 80 mL of tetrahydrofuran and 4 mL of dimethyl sulfoxide, add 4 and triphenylphosphine in sequence, and then slowly add azodiisopropyl ester dropwise in an ice-water bath for 30 minutes. After the addition, the resulting mixture was heated to 35°C and stirred for 1 h. The reaction was monitored by TLC. After the reaction was completed, saturated saline solution was added for quenching. The solution was extracted with ethyl acetate, washed with saturated aqueous sodium bicarbonate solution and brine, the organic phase was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated in vacuo. Purified by silica gel chromatography with dichloromethane/methanol=20/1. 5 was obtained (1.69 g, 88% yield).
1H NMR(400MHz,Chloroform-d)δ7.80–7.61(m,4H),7.45(td,J=7.8,1.9Hz,1H),7.17–7.05(m,2H),6.00(p,J=6.7Hz,1H),5.11(d,J=7.2Hz,2H),5.04(dd,J=6.6,3.4Hz,2H),3.56–3.51(m,3H),3.45–3.36(m,3H),1.68(dd,J=8.0,6.5Hz,3H).1H NMR(400MHz,Chloroform-d)δ7.80–7.61(m,4H),7.45(td,J=7.8,1.9Hz,1H),7.17–7.05(m,2H),6.00(p,J=6.7 Hz,1H),5.11(d,J=7.2Hz,2H),5.04(dd,J=6.6,3.4Hz,2H),3.56–3.51(m,3H),3.45–3.36(m,3H),1.68 (dd,J=8.0,6.5Hz,3H).
步骤41、化学反应式Step 41. Chemical reaction formula
2、投料配比2. Feeding ratio
3、操作过程3. Operation process
将产品5溶于乙醇中,加入80%水合肼,并使所得混合物在室温下搅拌1h。滤除固体,再加入水8ml,用乙酸乙酯萃取混合物,用饱和碳酸氢钠水溶液和盐水洗涤,用无水硫酸钠干燥,过滤,然后将滤液真空浓缩。经乙酸乙酯硅胶层析纯化,得到白色固体6(0.8g,0.0341mol,产率79%)。Product 5 was dissolved in ethanol, 80% hydrazine hydrate was added, and the resulting mixture was stirred at room temperature for 1 h. The solid was filtered off, and 8 ml of water was added. The mixture was extracted with ethyl acetate, washed with saturated aqueous sodium bicarbonate solution and brine, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated in vacuo. Purified by silica gel chromatography with ethyl acetate, a white solid 6 (0.8 g, 0.0341 mol, yield 79%) was obtained.
1H NMR(400MHz,DMSO-d6)δ7.13–6.94(m,3H),5.74(s,2H),5.26–5.14(m,2H),5.15–5.03(m,2H),4.97(t,J=6.5Hz,1H),3.51(s,3H),3.41(s,3H),1.28(d,J=6.5Hz,3H). 1 H NMR (400MHz, DMSO-d6) δ7.13–6.94(m,3H),5.74(s,2H),5.26–5.14(m,2H),5.15–5.03(m,2H),4.97(t, J=6.5Hz,1H),3.51(s,3H),3.41(s,3H),1.28(d,J=6.5Hz,3H).
步骤51、化学反应式Step 51. Chemical reaction formula
2、投料配比2. Feeding ratio
操作过程Operation process
在氮气氛围下,将化合物6溶解于乙醇中,随后加入化合物7和2滴醋酸,混合物在60℃下搅拌6小时,TLC监测反应,反应结束后,过滤除去不溶物,滤液减压蒸除溶剂,用二氯甲烷/甲醇=9/1在硅胶上层析纯化得到8(1.53g,产率90%)。Under a nitrogen atmosphere, compound 6 was dissolved in ethanol, and then compound 7 and 2 drops of acetic acid were added. The mixture was stirred at 60°C for 6 hours. The reaction was monitored by TLC. After the reaction, the insoluble matter was filtered to remove the insoluble matter, and the filtrate was evaporated under reduced pressure to remove the solvent. , purified by silica gel chromatography using dichloromethane/methanol = 9/1 to obtain 8 (1.53 g, yield 90%).
1H NMR(400MHz,DMSO-d6)δ8.88(s,2H),7.40–7.17(m,15H),7.10–6.98(m,3H),6.69(s,1H),5.52(q,J=6.5Hz,1H),5.25–5.15(m,2H),5.15–5.05(m,2H),3.49(s,3H),3.41(s,3H),1.40(d,J=6.6Hz,2H).步骤6:1H NMR (400MHz, DMSO-d6) δ8.88(s,2H),7.40–7.17(m,15H),7.10–6.98(m,3H),6.69(s,1H),5.52(q,J=6.5 Hz,1H),5.25–5.15(m,2H),5.15–5.05(m,2H),3.49(s,3H),3.41(s,3H),1.40(d,J=6.6Hz,2H). Steps 6:
1、化学反应式1. Chemical reaction formula
2、投料配比2. Feeding ratio
在氮气氛围下,将化合物34(2.02g,0.00309mol)溶解于N,N-二甲基甲酰胺(8.0mL)中,在零下30℃下依次滴加化合物氯磷酸二苯酯(576μL,0.0028mol)和N,N-二异丙基乙基胺(1.04mL,0.0059mol),在零下30℃反应2小时后,加入零下30℃冷却过的化合物16(794.6mg,0.0020mol)的N,N-二甲基甲酰胺(16.0mL)溶液,混合物在零下30℃下搅拌12小时,TLC监测反应,反应结束后,加入饱和碳酸氢钠淬灭反应,乙酸乙酯萃取,依次使用水和饱和食盐水洗涤,无水硫酸钠干燥,过滤除去不溶物,滤液减压蒸除溶剂,用乙酸乙酯在硅胶上层析纯化得到35(1.64g,产率83%)。Under a nitrogen atmosphere, compound 34 (2.02g, 0.00309mol) was dissolved in N,N-dimethylformamide (8.0mL), and compound diphenyl chlorophosphate (576μL, 0.0028) was added dropwise at minus 30°C. mol) and N,N-diisopropylethylamine (1.04mL, 0.0059mol), after reacting at minus 30°C for 2 hours, add the N of compound 16 (794.6mg, 0.0020mol) that has been cooled at minus 30°C. N-dimethylformamide (16.0 mL) solution, the mixture was stirred at minus 30°C for 12 hours, and the reaction was monitored by TLC. After the reaction was completed, saturated sodium bicarbonate was added to quench the reaction, and ethyl acetate was extracted. Water and saturated sodium bicarbonate were used in sequence. Wash with brine, dry over anhydrous sodium sulfate, filter to remove insoluble matter, evaporate the solvent from the filtrate under reduced pressure, and purify by silica gel chromatography with ethyl acetate to obtain 35 (1.64 g, yield 83%).
步骤7:Step 7:
1、化学反应式1. Chemical reaction formula
2、投料配比2. Feeding ratio
操作过程Operation process
将23(1.23g,0.00120mol)溶解于乙腈(43.0mL)和水(14.0mL)的混合溶液中,然后将所得混合物升温至40℃,加入碳酸氢钠(4.46g,0.0520mol),5分钟后加入保险粉(3.08g,0.0194mol)。溶液在40℃下搅拌10分钟,TLC监测反应,反应完成后,将反应液倒入二氯甲烷和水的混合溶液中,随后使用盐酸(2M)将pH调至3,二氯甲烷萃取,饱和食盐水洗涤,无水硫酸钠干燥,过滤除去干燥剂后真空浓缩。残留物经二氯甲烷/甲醇=20/1硅胶层析纯化,得到棕黄色固体37(999mg,产率92%)。Dissolve 23 (1.23g, 0.00120mol) in a mixed solution of acetonitrile (43.0mL) and water (14.0mL), then heat the resulting mixture to 40°C, add sodium bicarbonate (4.46g, 0.0520mol), and wait for 5 minutes. Then add insurance powder (3.08g, 0.0194mol). The solution was stirred at 40°C for 10 minutes, and the reaction was monitored by TLC. After the reaction was completed, the reaction solution was poured into a mixed solution of methylene chloride and water, and then the pH was adjusted to 3 using hydrochloric acid (2M), extracted with methylene chloride, and saturated. Wash with brine, dry over anhydrous sodium sulfate, filter to remove the desiccant and concentrate in vacuum. The residue was purified by silica gel chromatography with dichloromethane/methanol = 20/1 to obtain a brown solid 37 (999 mg, yield 92%).
步骤8:Step 8:
1、化学反应式1. Chemical reaction formula
2、投料配比2. Feeding ratio
氮气氛围下,将37(900mg,0.00994mol)溶解于无水二氯甲烷(5mL)中,然后加入三乙基硅烷(476μL,0.00298mol)并将所得混合物冷却至零下15℃,加入三氟乙酸(7.61mL,0.1mol)。溶液在零下15℃下搅拌12小时后,将反应液逐步升温至室温继续搅拌3小时。真空浓缩除去挥发物和溶剂后,残留物加入叔丁基甲基醚得到白色固体,在超声波中超声10分钟后,使用离心机离心10分钟,将上层清液除去,继续重复叔丁基甲基醚-超声-离心步骤两次,所得固体经油泵减压除去溶剂后即为产物D(551mg,产率96.5%)。Under nitrogen atmosphere, dissolve 37 (900 mg, 0.00994 mol) in anhydrous dichloromethane (5 mL), then add triethylsilane (476 μL, 0.00298 mol) and cool the resulting mixture to minus 15°C, and add trifluoroacetic acid (7.61mL, 0.1mol). After the solution was stirred at minus 15°C for 12 hours, the reaction solution was gradually warmed to room temperature and continued to stir for 3 hours. After vacuum concentration to remove volatile matter and solvent, tert-butyl methyl ether was added to the residue to obtain a white solid. After ultrasonic for 10 minutes, centrifuge for 10 minutes using a centrifuge to remove the supernatant and continue to repeat tert-butyl methyl ether - ultrasonic - The solid was centrifuged twice and the solvent was removed under reduced pressure using an oil pump to obtain product D (551 mg, yield 96.5%).
实施例3Example 3
步骤11、化学反应式Step 11. Chemical reaction formula
2、投料配比2. Feeding ratio
将2,3-二羟基苯甲醛11.1g溶解于丙酮300m L中,冰水浴下加入碳酸钾55.2g,随后缓慢滴加氯甲基甲醚18.2mL。滴加完成后,将反应升温至室温并继续搅拌30分钟。反应完成后,抽滤除去不溶物,并使用丙酮洗涤。所得滤液真空除去大部分丙酮溶剂后加入乙酸乙酯和水,乙酸乙酯萃取,Dissolve 11.1g of 2,3-dihydroxybenzaldehyde in 300mL of acetone, add 55.2g of potassium carbonate in an ice-water bath, and then slowly add 18.2mL of chloromethyl methyl ether dropwise. After the addition was complete, the reaction was warmed to room temperature and stirring continued for 30 minutes. After the reaction was completed, the insoluble matter was removed by suction filtration and washed with acetone. Most of the acetone solvent was removed from the obtained filtrate under vacuum, then ethyl acetate and water were added, and extracted with ethyl acetate.
合并有机相,有机相使用饱和食盐水洗涤,无水硫酸钠干燥,过滤,滤液在真空中浓缩,残留物经石油醚/乙酸乙酯在硅胶柱上层析纯化,石油醚/乙酸乙酯的体积比为20/1,得到无色液体2 17.45g,收率96%。1H NMR(400MHz,Chloroform-d)δ10.46(s,1H),7.51(d,J=7.8Hz,1H),7.41(d,J=8.2Hz,1H),7.21–7.10(m,1H),5.26(s,2H),5.24(s,2H),3.58(s,3H),3.52(s,3H).质谱如图1所示。Combine the organic phases, wash the organic phases with saturated brine, dry over anhydrous sodium sulfate, filter, and concentrate the filtrate in a vacuum. The residue is purified by silica gel column chromatography with petroleum ether/ethyl acetate. The volume ratio was 20/1, and 17.45g of colorless liquid 2 was obtained, with a yield of 96%. 1 H NMR (400MHz, Chloroform-d) δ10.46 (s, 1H), 7.51 (d, J = 7.8Hz, 1H), 7.41 (d, J = 8.2Hz, 1H), 7.21–7.10 (m, 1H ), 5.26(s,2H), 5.24(s,2H), 3.58(s,3H), 3.52(s,3H). The mass spectrum is shown in Figure 1.
步骤21、化学反应式Step 21. Chemical reaction formula
2、投料配比2. Feeding ratio
操作过程Operation process
将2溶于THF溶液在氮气气氛下冷却至零下20℃,然后滴加乙基溴化镁的THF溶液使反应混合物保持在10℃以下。加入之后,将混合物加热至室温,搅拌3小时,然后用饱和NH4Cl水溶液缓慢加入使混合物淬灭。溶液用乙酸乙酯提取,用盐水洗涤,用无水硫酸钠干燥,过滤后真空浓缩。以石油谜/乙酸乙酯=10/1为洗脱液,采用硅胶柱层析纯化,得到液体3(10.84g,产率80%)。A solution of 2 dissolved in THF was cooled to minus 20°C under a nitrogen atmosphere, and then a THF solution of ethyl magnesium bromide was added dropwise to keep the reaction mixture below 10°C. After addition, the mixture was warmed to room temperature, stirred for 3 hours, and then quenched with saturated aqueous NH4Cl solution added slowly. The solution was extracted with ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. Using petroleum methane/ethyl acetate = 10/1 as the eluent, the product was purified by silica gel column chromatography to obtain liquid 3 (10.84 g, yield 80%).
1H NMR(400MHz,Chloroform-d)δ7.22–7.12(m,5H),7.04–6.93(m,3H),5.21–5.15(m,1H),5.11(s,2H),5.06–5.00(m,2H),3.49(s,3H),3.41(s,3H),3.06(dd,J=13.8,4.6Hz,1H),2.95(dd,J=13.8,8.9Hz,1H).1H NMR(400MHz,Chloroform-d)δ7.22–7.12(m,5H),7.04–6.93(m,3H),5.21–5.15(m,1H),5.11(s,2H),5.06–5.00(m ,2H),3.49(s,3H),3.41(s,3H),3.06(dd,J=13.8,4.6Hz,1H),2.95(dd,J=13.8,8.9Hz,1H).
步骤31、化学反应式Step 31. Chemical reaction formula
2、投料配比2. Feeding ratio
操作过程Operation process
将3溶解于四氢呋喃的混合溶剂中,依次加入4和三苯基膦,随后在冰水浴下缓慢滴加偶氮二异丙酯30分钟。加入之后,将所得混合物升温至35℃并搅拌1h,TLC监测反应,待反应完成后加入饱和食盐水溶液进行淬灭。溶液用乙酸乙酯提取,用饱和碳酸氢钠水溶液和盐水洗涤,有机相用无水硫酸钠干燥,过滤,然后将滤液真空浓缩。经二氯甲烷/甲醇=20/1硅胶层析纯化。得到5(1.8g,产率78%)。Dissolve 3 in a mixed solvent of tetrahydrofuran, add 4 and triphenylphosphine in sequence, and then slowly add azodiisopropyl ester dropwise in an ice-water bath for 30 minutes. After the addition, the resulting mixture was heated to 35°C and stirred for 1 h. The reaction was monitored by TLC. After the reaction was completed, saturated saline solution was added for quenching. The solution was extracted with ethyl acetate, washed with saturated aqueous sodium bicarbonate solution and brine, the organic phase was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated in vacuo. Purified by silica gel chromatography with dichloromethane/methanol=20/1. 5 was obtained (1.8 g, 78% yield).
1H NMR(400MHz,Chloroform-d)δ7.75–7.68(m,2H),7.66–7.61(m,2H),7.51(dd,J=7.7,1.7Hz,1H),7.33–7.28(m,2H),7.27–7.22(m,2H),7.20–7.12(m,2H),7.08(dd,J=8.2,1.7Hz,1H),6.19(dd,J=7.8,5.9Hz,1H),5.07(d,J=1.3Hz,2H),4.91(d,J=5.6Hz,1H),4.82(d,J=5.6Hz,1H),3.46(s,4H),3.38(s,3H),3.27(dd,J=14.5,5.8Hz,1H). 1 H NMR (400MHz, Chloroform-d) δ7.75–7.68(m,2H),7.66–7.61(m,2H),7.51(dd,J=7.7,1.7Hz,1H),7.33–7.28(m, 2H),7.27–7.22(m,2H),7.20–7.12(m,2H),7.08(dd,J=8.2,1.7Hz,1H),6.19(dd,J=7.8,5.9Hz,1H),5.07 (d,J=1.3Hz,2H),4.91(d,J=5.6Hz,1H),4.82(d,J=5.6Hz,1H),3.46(s,4H),3.38(s,3H),3.27 (dd,J=14.5,5.8Hz,1H).
步骤41、化学反应式Step 41. Chemical reaction formula
2、投料配比2. Feeding ratio
将产品5溶于乙醇中,加入80%水合肼,并使所得混合物在室温下搅拌1h。滤除固体,再加入水,用乙酸乙酯萃取混合物,用饱和碳酸氢钠水溶液和盐水洗涤,用无水硫酸钠干燥,过滤,然后将滤液真空浓缩。经乙酸乙酯硅胶层析纯化,得到白色固体6(0.9g,产率75%)。Product 5 was dissolved in ethanol, 80% hydrazine hydrate was added, and the resulting mixture was stirred at room temperature for 1 h. The solid was filtered off, water was added, the mixture was extracted with ethyl acetate, washed with saturated aqueous sodium bicarbonate solution and brine, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated in vacuo. Purification by ethyl acetate silica gel chromatography gave a white solid 6 (0.9 g, yield 75%).
1H NMR(400MHz,DMSO-d6)δ7.24(dd,J=8.7,6.1Hz,2H),7.17(d,J=7.2Hz,3H),7.09–6.98(m,3H),5.22–5.10(m,3H),5.06(d,J=5.5Hz,1H),4.98(d,J=5.4Hz,1H),3.49(s,3H),3.40(s,3H),2.90(d,J=6.5Hz,2H).1H NMR (400MHz, DMSO-d6) δ7.24(dd,J=8.7,6.1Hz,2H),7.17(d,J=7.2Hz,3H),7.09–6.98(m,3H),5.22–5.10( m,3H),5.06(d,J=5.5Hz,1H),4.98(d,J=5.4Hz,1H),3.49(s,3H),3.40(s,3H),2.90(d,J=6.5 Hz,2H).
步骤51、化学反应式Step 51. Chemical reaction formula
2、投料配比2. Feeding ratio
操作过程Operation process
在氮气氛围下,将化合物6溶解于乙醇中,随后加入化合物7和2滴醋酸,混合物在60℃下搅拌6小时,TLC监测反应,反应结束后,过滤除去不溶物,滤液减压蒸除溶剂,用二氯甲烷/甲醇=20/1在硅胶上层析纯化得到8(1.7g,产率85%)。Under a nitrogen atmosphere, compound 6 was dissolved in ethanol, and then compound 7 and 2 drops of acetic acid were added. The mixture was stirred at 60°C for 6 hours. The reaction was monitored by TLC. After the reaction, the insoluble matter was filtered to remove the insoluble matter, and the filtrate was evaporated under reduced pressure to remove the solvent. , purified by silica gel chromatography using dichloromethane/methanol = 20/1 to obtain 8 (1.7 g, yield 85%).
1H NMR(400MHz,DMSO-d6)δ7.45–6.86(m,22H),6.67(s,1H),5.60(dd,J=7.8,5.0Hz,1H),5.27–5.13(m,2H),5.12–4.93(m,2H),3.42(d,J=13.3Hz,6H),3.02(s,2H). 1 H NMR (400MHz, DMSO-d 6 ) δ7.45–6.86 (m, 22H), 6.67 (s, 1H), 5.60 (dd, J = 7.8, 5.0Hz, 1H), 5.27–5.13 (m, 2H) ),5.12–4.93(m,2H),3.42(d,J=13.3Hz,6H),3.02(s,2H).
步骤61、化学反应式Step 61. Chemical reaction formula
投料配比Feeding ratio
操作过程Operation process
在氮气氛围下,将化合物34(2.02g,0.00277mol)溶解于N,N-二甲基甲酰胺(8.0mL)中,在零下30℃下依次滴加化合物氯磷酸二苯酯(564μL,0.0028mol)和N,N-二异丙基乙基胺(0.82mL,0.0059mol),在零下30℃反应2小时后,加入零下30℃冷却过的化合物16(710.8mg,0.0020mol)的N,N-二甲基甲酰胺(16.0mL)溶液,混合物在零下30℃下搅拌12小时,TLC监测反应,反应结束后,加入饱和碳酸氢钠淬灭反应,乙酸乙酯萃取,依次使用水和饱和食盐水洗涤,无水硫酸钠干燥,过滤除去不溶物,滤液减压蒸除溶剂,用乙酸乙酯在硅胶上层析纯化得到35(1.53g,产率79%)。Under a nitrogen atmosphere, compound 34 (2.02g, 0.00277mol) was dissolved in N,N-dimethylformamide (8.0mL), and the compound diphenyl chlorophosphate (564μL, 0.0028) was added dropwise at minus 30°C. mol) and N,N-diisopropylethylamine (0.82mL, 0.0059mol), after reacting at minus 30°C for 2 hours, add the N of compound 16 (710.8mg, 0.0020mol) that has been cooled at minus 30°C. N-dimethylformamide (16.0 mL) solution, the mixture was stirred at minus 30°C for 12 hours, and the reaction was monitored by TLC. After the reaction was completed, saturated sodium bicarbonate was added to quench the reaction, and extracted with ethyl acetate, using water and saturated Wash with brine, dry over anhydrous sodium sulfate, filter to remove insoluble matter, evaporate the solvent from the filtrate under reduced pressure, and purify by silica gel chromatography with ethyl acetate to obtain 35 (1.53 g, yield 79%).
步骤7:Step 7:
1、化学反应式1. Chemical reaction formula
2、投料配比2. Feeding ratio
操作过程Operation process
将36(1.23g,0.00120mol)溶解于乙腈(43.0mL)和水(14.0mL)的混合溶液中,然后将所得混合物升温至40℃,加入碳酸氢钠(4.07g,0.0520mol),5分钟后加入保险粉(2.81g,0.0194mol)。溶液在40℃下搅拌10分钟,TLC监测反应,反应完成后,将反应液倒入二氯甲烷和水的混合溶液中,随后使用盐酸(2M)将pH调至3,二氯甲烷萃取,饱和食盐水洗涤,无水硫酸钠干燥,过滤除去干燥剂后真空浓缩。残留物经二氯甲烷/甲醇=20/1硅胶层析纯化,得到棕黄色固体37(907mg,0.00092mol,产率84%)。Dissolve 36 (1.23g, 0.00120mol) in a mixed solution of acetonitrile (43.0mL) and water (14.0mL), then heat the resulting mixture to 40°C, add sodium bicarbonate (4.07g, 0.0520mol), and wait for 5 minutes. Then add insurance powder (2.81g, 0.0194mol). The solution was stirred at 40°C for 10 minutes, and the reaction was monitored by TLC. After the reaction was completed, the reaction solution was poured into a mixed solution of methylene chloride and water, and then the pH was adjusted to 3 using hydrochloric acid (2M), extracted with methylene chloride, and saturated. Wash with brine, dry over anhydrous sodium sulfate, filter to remove the desiccant and concentrate in vacuum. The residue was purified by silica gel chromatography with dichloromethane/methanol = 20/1 to obtain brown solid 37 (907 mg, 0.00092 mol, yield 84%).
步骤81、化学反应式Step 81. Chemical reaction formula
2、投料配比2. Feeding ratio
操作过程Operation process
氮气氛围下,将37(900mg,0.00994mol)溶解于无水二氯甲烷(5mL)中,然后加入三乙基硅烷(476μL,0.00298mol)并将所得混合物冷却至零下15℃,加入三氟乙酸(7.61mL,0.1mol)。溶液在零下15℃下搅拌12小时后,将反应液逐步升温至室温继续搅拌3小时。真空浓缩除去挥发物和溶剂后,残留物加入叔丁基甲基醚得到白色固体,在超声波中超声10分钟后,使用离心机离心10分钟,将上层清液除去,继续重复叔丁基甲基醚-超声-离心步骤两次,所得固体经油泵减压除去溶剂后即为产物D(573mg,0.0088mol,产率96%)。Under nitrogen atmosphere, dissolve 37 (900 mg, 0.00994 mol) in anhydrous dichloromethane (5 mL), then add triethylsilane (476 μL, 0.00298 mol) and cool the resulting mixture to minus 15°C, and add trifluoroacetic acid (7.61mL, 0.1mol). After the solution was stirred at minus 15°C for 12 hours, the reaction solution was gradually warmed to room temperature and continued to stir for 3 hours. After vacuum concentration to remove volatile matter and solvent, tert-butyl methyl ether was added to the residue to obtain a white solid. After ultrasonic for 10 minutes, centrifuge for 10 minutes using a centrifuge to remove the supernatant and continue to repeat tert-butyl methyl ether - ultrasonic - The solid was centrifuged twice and the solvent was removed under reduced pressure by an oil pump to obtain product D (573 mg, 0.0088 mol, yield 96%).
实施例4Example 4
1、化学反应式1. Chemical reaction formula
2、投料配比2. Feeding ratio
操作过程Operation process
将2溶于THF,在氮气气氛下冷却至零下20℃,然后滴加环己基溴化镁的THF溶液使反应混合物保持在10℃以下。加入之后,将混合物加热至室温,搅拌3小时,然后用饱和NH4Cl水溶液缓慢加入使混合物淬灭。溶液用乙酸乙酯提取,用盐水洗涤,用无水硫酸钠干燥,过滤后真空浓缩。以石油谜/乙酸乙酯=10/1为洗脱液,采用硅胶柱层析纯化,得到液体9(544mg,产率79%)。Dissolve 2 in THF, cool to minus 20°C under a nitrogen atmosphere, and then add a THF solution of cyclohexylmagnesium bromide dropwise to keep the reaction mixture below 10°C. After addition, the mixture was warmed to room temperature, stirred for 3 hours, and then quenched with saturated aqueous NH4Cl solution added slowly. The solution was extracted with ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. Purify by silica gel column chromatography using petroleum methane/ethyl acetate = 10/1 as the eluent to obtain liquid 9 (544 mg, yield 79%).
1H NMR(400MHz,Chloroform-d)δ7.03–6.89(m,3H),5.11(d,J=1.0Hz,2H),5.04(s,2H),4.57(d,J=8.2Hz,1H),3.51(s,3H),3.42(s,3H),2.40(s,1H),2.03(dt,J=12.5,3.5Hz,1H),1.74–1.67(m,2H),1.59–1.52(m,2H),1.30–1.22(m,1H),1.21–1.14(m,2H),1.13–1.04(m,3H). 1 H NMR (400MHz, Chloroform-d) δ7.03–6.89 (m, 3H), 5.11 (d, J = 1.0Hz, 2H), 5.04 (s, 2H), 4.57 (d, J = 8.2Hz, 1H ),3.51(s,3H),3.42(s,3H),2.40(s,1H),2.03(dt,J=12.5,3.5Hz,1H),1.74–1.67(m,2H),1.59–1.52( m,2H),1.30–1.22(m,1H),1.21–1.14(m,2H),1.13–1.04(m,3H).
实施例5Example 5
1、化学反应式1. Chemical reaction formula
2、投料配比2. Feeding ratio
操作过程Operation process
将2溶于THF溶液在氮气气氛下冷却至零下20℃,然后滴加苯基溴化镁的THF溶液使反应混合物保持在10℃以下。加入之后,将混合物加热至室温,搅拌3小时,然后用饱和NH4Cl水溶液缓慢加入使混合物淬灭。溶液用乙酸乙酯提取,用盐水洗涤,用无水硫酸钠干燥,过滤后真空浓缩。以石油谜/乙酸乙酯=10/1为洗脱液,采用硅胶柱层析纯化,得到液体10(570mg,产率85%)。A solution of 2 dissolved in THF was cooled to minus 20°C under a nitrogen atmosphere, and then a THF solution of phenylmagnesium bromide was added dropwise to keep the reaction mixture below 10°C. After addition, the mixture was warmed to room temperature, stirred for 3 hours, and then quenched with saturated aqueous NH4Cl solution added slowly. The solution was extracted with ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. Using petroleum methane/ethyl acetate = 10/1 as the eluent, the product was purified by silica gel column chromatography to obtain liquid 10 (570 mg, yield 85%).
1H NMR(400MHz,Chloroform-d)δ7.38–7.29(m,2H),7.24(t,J=7.6Hz,2H),7.19–7.09(m,1H),6.99(dd,J=8.2,1.6Hz,1H),6.90(t,J=8.0Hz,1H),6.74–6.66(m,1H),6.11(s,1H),5.09(d,J=1.0Hz,2H),5.07–5.01(m,1H),4.97(d,J=5.9Hz,1H),3.46(d,J=1.3Hz,3H),3.40(s,3H),3.33–2.88(m,1H).实施例6 1 H NMR(400MHz,Chloroform-d)δ7.38–7.29(m,2H),7.24(t,J=7.6Hz,2H),7.19–7.09(m,1H),6.99(dd,J=8.2, 1.6Hz,1H),6.90(t,J=8.0Hz,1H),6.74–6.66(m,1H),6.11(s,1H),5.09(d,J=1.0Hz,2H),5.07–5.01( m, 1H), 4.97 (d, J = 5.9Hz, 1H), 3.46 (d, J = 1.3Hz, 3H), 3.40 (s, 3H), 3.33–2.88 (m, 1H). Example 6
1、化学反应式1. Chemical reaction formula
2、投料配比2. Feeding ratio
3、操作过程3. Operation process
将2溶于THF溶液在氮气气氛下冷却至零下20℃,然后滴加乙基溴化镁的THF溶液使反应混合物保持在10℃以下。加入之后,将混合物加热至室温,搅拌3小时,然后用饱和NH4Cl水溶液缓慢加入使混合物淬灭。溶液用乙酸乙酯提取,用盐水洗涤,用无水硫酸钠干燥,过滤后真空浓缩。以石油谜/乙酸乙酯=10/1为洗脱液,采用硅胶柱层析纯化,得到液体11(460mg,产率82%)。A solution of 2 dissolved in THF was cooled to minus 20°C under a nitrogen atmosphere, and then a THF solution of ethyl magnesium bromide was added dropwise to keep the reaction mixture below 10°C. After addition, the mixture was warmed to room temperature, stirred for 3 hours, and then quenched with saturated aqueous NH4Cl solution added slowly. The solution was extracted with ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. Using petroleum methane/ethyl acetate = 10/1 as the eluent, the product was purified by silica gel column chromatography to obtain liquid 11 (460 mg, yield 82%).
1H NMR(400MHz,Chloroform-d)δ7.06–6.91(m,3H),5.14–5.09(m,2H),5.05(pd,J=6.0,5.2,3.6Hz,2H),4.84(ddd,J=7.6,5.9,1.5Hz,1H),3.56–3.47(m,3H),3.47–3.37(m,3H),2.54(s,1H),1.89–1.65(m,2H),0.95–0.83(m,3H). 1 H NMR (400MHz, Chloroform-d) δ7.06–6.91 (m, 3H), 5.14–5.09 (m, 2H), 5.05 (pd, J = 6.0, 5.2, 3.6Hz, 2H), 4.84 (ddd, J=7.6,5.9,1.5Hz,1H),3.56–3.47(m,3H),3.47–3.37(m,3H),2.54(s,1H),1.89–1.65(m,2H),0.95–0.83( m,3H).
本发明不局限于上述实施例,本领域的普通技术人员可以理解:在不脱离本发明的原理和宗旨的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由权利要求及其等同物限定。The present invention is not limited to the above-described embodiments. Those of ordinary skill in the art can understand that various changes, modifications, substitutions and modifications can be made to these embodiments without departing from the principles and purposes of the present invention. The scope of the present invention Defined by the claims and their equivalents.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310686885.4A CN116731039B (en) | 2023-06-12 | 2023-06-12 | Process for the preparation of cephalosporin derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310686885.4A CN116731039B (en) | 2023-06-12 | 2023-06-12 | Process for the preparation of cephalosporin derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116731039A true CN116731039A (en) | 2023-09-12 |
CN116731039B CN116731039B (en) | 2025-02-18 |
Family
ID=87905618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310686885.4A Active CN116731039B (en) | 2023-06-12 | 2023-06-12 | Process for the preparation of cephalosporin derivatives |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116731039B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1478093A (en) * | 2000-12-04 | 2004-02-25 | �Ʒ� | Coupling process and intermediates useful for preparing cephalosphorins |
CN105213363A (en) * | 2015-04-30 | 2016-01-06 | 中国科学院微生物研究所 | The application of hydroquinone farnesyl compounds |
CN105254648A (en) * | 2015-11-13 | 2016-01-20 | 广东温氏大华农生物科技有限公司 | Convenia synthetic method and Convenia sodium salt synthetic method |
CN113336775A (en) * | 2021-06-21 | 2021-09-03 | 湖北凌晟药业有限公司 | Synthesis method of cefotaxime intermediate |
CN114213433A (en) * | 2020-06-08 | 2022-03-22 | 重庆医药高等专科学校 | Preparation method of C-3 tetrahydrofuran substituted cephalosporin-siderophore conjugate |
-
2023
- 2023-06-12 CN CN202310686885.4A patent/CN116731039B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1478093A (en) * | 2000-12-04 | 2004-02-25 | �Ʒ� | Coupling process and intermediates useful for preparing cephalosphorins |
CN105213363A (en) * | 2015-04-30 | 2016-01-06 | 中国科学院微生物研究所 | The application of hydroquinone farnesyl compounds |
CN105254648A (en) * | 2015-11-13 | 2016-01-20 | 广东温氏大华农生物科技有限公司 | Convenia synthetic method and Convenia sodium salt synthetic method |
CN114213433A (en) * | 2020-06-08 | 2022-03-22 | 重庆医药高等专科学校 | Preparation method of C-3 tetrahydrofuran substituted cephalosporin-siderophore conjugate |
CN113336775A (en) * | 2021-06-21 | 2021-09-03 | 湖北凌晟药业有限公司 | Synthesis method of cefotaxime intermediate |
Also Published As
Publication number | Publication date |
---|---|
CN116731039B (en) | 2025-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106243111A (en) | The method of synthesis E1 activating enzyme inhibitors | |
CN118165048A (en) | Method for preparing oxy-glycoside compound and application of glycosyl donor in preparing oxy-glycoside compound | |
EP3406619B1 (en) | Method and intermediate for preparing tulathromycin | |
CN110092740A (en) | A kind of fused ring compound and its application | |
CN109824565B (en) | Light-responsive multifunctional chemical cross-linking agent and preparation method and application thereof | |
CN113999252A (en) | Cefpodoxime proxetil impurity cefpodoxime dippivoxil and preparation method thereof | |
CN116731039A (en) | Process for the preparation of cephalosporin derivatives | |
CN116730808B (en) | Preparation method of cefvicin derivative intermediate | |
WO2024193472A1 (en) | 1h-pyrrole-2-amide derivative and use thereof | |
JP2013537534A (en) | Process for the preparation of compound OSI-906 | |
CN114426538B (en) | A kind of berberine canagliflozin derivative and its preparation method and application | |
CN114524748B (en) | Preparation method of roflumilast intermediate and Luo Shasi | |
CN101805380B (en) | Method for preparing (3S, 5S)-2, 3-dihydroxyl-5-hydroxymethyl tetrahydrofuran triacetate | |
CN114315679A (en) | Preparation method of Upactinib chiral intermediate | |
CN114436880A (en) | Preparation method of iopromide intermediate | |
CN105001200A (en) | Preparation method of anti-angiogenesis compound and intermediate thereof | |
CN116284018B (en) | A preparation method and application of furano[2,3-b]quinoline derivative | |
JP2906228B2 (en) | Glucopyranose derivative salt | |
CN114874132B (en) | Preparation method of recombinant human receptor protein FKBP12 ligand | |
CN102786527A (en) | Tailed porphyrin compound modified by N1-substituted 3, 4-dihydropyrimidine-2-ketone and preparation method thereof | |
WO2022160737A1 (en) | Crystal form of tetrahydropyran ring compound and preparation method therefor | |
CN108456157A (en) | 1- substituted benzoyl -4- fatty acyl group amino carbamide derivative, preparation method and the purposes as antibacterials | |
CN109535060B (en) | Hedgehog pathway inhibitor and preparation method and application thereof | |
JP2024541775A (en) | Salt and crystal forms of sulfonylurea ring-substituted compounds | |
CN119528904A (en) | Indole derivatives having antibacterial activity, process for their preparation, their use, pharmaceutical compositions and medical devices made thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Country or region after: China Address after: 401120 No. 19 Zhuoyue Road, Longxing Town, Liangjiang New Area, Yubei District, Chongqing (cluster registration) Applicant after: Chongqing Hanpei Biotechnology Co.,Ltd. Address before: Room 505-099, Building 9, Chongqing Railway Port Public Logistics Warehouse Project, Standard Division I, Xiyong Group, Tuzhu Street, Shapingba District, Chongqing, 400000 Applicant before: Chongqing Hanpei Biotechnology Co.,Ltd. Country or region before: China |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |